HIP1 as a marker of aggressive prostate cancer

E Y W Chan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).
LanguageEnglish
Pages372-375
Number of pages4
JournalClinical Genetics
Volume62
Issue number5
DOIs
Publication statusPublished - Nov 2002

Fingerprint

Prostatic Neoplasms
Huntington Disease
Neurodegenerative Diseases
Cell Survival
Cytoplasm
Huntingtin Protein
Proteins

Keywords

  • carrier proteins
  • DNA-binding proteins
  • humans
  • male
  • prostate-specific antigen
  • prostatic neoplasms
  • tumor markers, biological

Cite this

Chan, E Y W. / HIP1 as a marker of aggressive prostate cancer. In: Clinical Genetics. 2002 ; Vol. 62, No. 5. pp. 372-375.
@article{b36b9faf58da4dd3b018569195e6df06,
title = "HIP1 as a marker of aggressive prostate cancer",
abstract = "A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).",
keywords = "carrier proteins, DNA-binding proteins, humans, male, prostate-specific antigen, prostatic neoplasms, tumor markers, biological",
author = "Chan, {E Y W}",
year = "2002",
month = "11",
doi = "10.1034/j.1399-0004.2002.620503_4.x",
language = "English",
volume = "62",
pages = "372--375",
journal = "Clinical Genetics",
issn = "0009-9163",
number = "5",

}

HIP1 as a marker of aggressive prostate cancer. / Chan, E Y W.

In: Clinical Genetics, Vol. 62, No. 5, 11.2002, p. 372-375.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HIP1 as a marker of aggressive prostate cancer

AU - Chan, E Y W

PY - 2002/11

Y1 - 2002/11

N2 - A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).

AB - A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).

KW - carrier proteins

KW - DNA-binding proteins

KW - humans

KW - male

KW - prostate-specific antigen

KW - prostatic neoplasms

KW - tumor markers, biological

U2 - 10.1034/j.1399-0004.2002.620503_4.x

DO - 10.1034/j.1399-0004.2002.620503_4.x

M3 - Article

VL - 62

SP - 372

EP - 375

JO - Clinical Genetics

T2 - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 5

ER -